PATENT CLAIM ANALYSIS

Application Number: 16043822
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-02
Patent Classification: ["514", "04400R"]

Abstract:
The invention relates to methods and compositions for treating a neurodegenerative disease. More particularly, the present invention is directed to methods of treatment of neurodegenerative diseases using progranulin and progranulin polypeptides, and methods of treatment of neurodegenerative diseases using effectors, or combinations of effectors, that modify progranulin expression.

Claim (Index 45):
A method for treating a patient with a neurodegenerative disease, said method comprising the steps of\n administering to the patient a composition comprising an effector that modifies progranulin expression; and reducing the symptoms of the neurodegenerative disease in the patient.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 95.0
- Lexical Diversity: 1.6875
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13126704', '15285359', '15867609', '11477730', '13435825']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7223656890986901
- 35 USC 102 Novelty (BERT): 0.5078784546362364
- Combined Prediction Score: 0.7009169656524448
- Mean Citation Score: 221.755498
- Max Citation Score: 254.83965
- Similarity Product: 167.06488768840134

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test